Results 91 to 100 of about 36,987 (240)
Reinke's Edema: From the Operating Theater to Office‐Based Blue Laser Treatment
In this retrospective study, 52 patients with Reinke's edema treated with office‐based 445‐nm blue laser were compared with a historical cohort of 40 patients treated by microlaryngoscopy under general anesthesia. Office‐based treatment was associated with significant improvement in Voice Handicap Index‐10 scores (15.0–2.0; p < 0.001) and complete ...
Francesco Mora +5 more
wiley +1 more source
Disease-specific complications of chronic lymphocytic leukemia in binet stage a patients [PDF]
Disease-specific Complications of Chronic Lymphocytic Leukemia in Binet Stage A Patients: Analysis of Immunodeficiency, Autoimmune Constellations and Infections in the CLL1-Protocol.
Kwag, Doo Young
core +1 more source
PB2673: EXPERIENCES AND VIEWS OF LEUKEMIA CARERS: A GLOBAL SURVEY
Samantha Nier +11 more
doaj +1 more source
Linking SLAMF1 to autophagy and sensitivity to therapy in chronic lymphocytic leukemia
We recently reported that expression of the costimulatory molecule and microbial sensor SLAMF1 (signaling lymphocytic activation molecule family 1, also known as CD150) is lost in chronic lymphocytic leukemia (CLL) patients characterized by a shorter ...
Cinzia Bologna, Silvia Deaglio
doaj +1 more source
ROR1 – a receptor tyrosine kinase – is overexpressed in CLL. Ibrutinib, a Bruton's tyrosine kinase inhibitor, is clinically effective in CLL but patients may develop resistance. We evaluated the effect of an ROR1 inhibitor, KAN0441571C, in CLL cells from
Schultz, Johan +29 more
core +1 more source
Abstract The prognostic and predictive impact of TP53 variants in leukemia led to their inclusion in diagnostic and treatment guidelines, increasing the demand for rapid, reliable laboratory analysis, interpretation, and reporting. While most TP53 variants identified in tumor samples can be interpreted using data from large‐scale functional studies ...
Šárka Pavlová +28 more
wiley +1 more source
Polyserositis as an Initial Manifestation of Chronic Lymphocytic Lymphoma
Chronic lymphocytic lymphoma (CLL) is a lymphoproliferative malignancy characterized by the generation and accumulation of CD5+ monoclonal B-cell lymphocytes, which are physically mature lymphocytes with aberrant immunological activity.
Sunita Aggarwal +7 more
doaj +1 more source
Management of CLL in the elderly
Management of CLL in the ...
CUNEO, Antonio, Foã , R.
openaire +4 more sources

